Cytarabine may induce bradycardia in patients being treated for non-Hodgkin lymphoma.
May signal cytarabine-related bradycardia in non-Hodgkin lymphoma; single case leaves open causality and monitoring needs.
Cytarabine (Ara-C) is an arabinose nucleoside in the group of antimetabolite anticancer drugs. It is one of the critical agents for the treatment of acute myelogenous leukemia (AML). Moreover, Ara-...
No takes yet. Share an insight, caveat, or question.
Çil et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: